Found: 17
Select item for more details and to access through your institution.
Influence of COVID‐19 pandemic on molar pregnancy and postmolar gestational trophoblastic neoplasia: An observational study.
- Published in:
- BJOG: An International Journal of Obstetrics & Gynaecology, 2023, v. 130, n. 3, p. 292, doi. 10.1111/1471-0528.17313
- By:
- Publication type:
- Article
Insurance status and cancer treatment mediate the association between race/ethnicity and cervical cancer survival.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0193047
- By:
- Publication type:
- Article
Experience With the Use of an Online Community on Facebook for Brazilian Patients With Gestational Trophoblastic Disease: Netnography Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Triaging abnormal cervical cancer screening tests using p16INK4a detection by ELISA on fresh cervical samples.
- Published in:
- American Journal of Reproductive Immunology, 2021, v. 86, n. 1, p. 1, doi. 10.1111/aji.13394
- By:
- Publication type:
- Article
Disease Distribution at Presentation Impacts Benefit of IP Chemotherapy Among Patients with Advanced-Stage Ovarian Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 11, p. 6705, doi. 10.1245/s10434-021-09746-w
- By:
- Publication type:
- Article
Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia.
- Published in:
- PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0277892
- By:
- Publication type:
- Article
PET-CT vs. CT alone in ovarian cancer recurrence.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Loss of Selenoprotein Iodothyronine Deiodinase 3 Expression Correlates with Progression of Complete Hydatidiform Mole to Gestational Trophoblastic Neoplasia.
- Published in:
- Reproductive Sciences, 2021, v. 28, n. 11, p. 3200, doi. 10.1007/s43032-021-00634-y
- By:
- Publication type:
- Article
Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention.
- Published in:
- Journal of Pathology, 2022, v. 257, n. 3, p. 255, doi. 10.1002/path.5891
- By:
- Publication type:
- Article
Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high‐grade serous carcinomas.
- Published in:
- Journal of Pathology, 2018, v. 246, n. 3, p. 344, doi. 10.1002/path.5145
- By:
- Publication type:
- Article
What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Complications of pelvic radiation in patients treated for gynecologic malignancies.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 24, p. 3870, doi. 10.1002/cncr.28849
- By:
- Publication type:
- Article
Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient TP53 Mutant Uterine Carcinomas Is Linked to the Summation of LKB1–AKT–p53 Interactions.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2195, doi. 10.3390/cancers13092195
- By:
- Publication type:
- Article
Phase II, 2‐stage, 2‐arm, PIK3CA mutation stratified trial of MK‐2206 in recurrent endometrial cancer.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 2, p. 413, doi. 10.1002/ijc.32783
- By:
- Publication type:
- Article
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma.
- Published in:
- Clinical Ovarian Cancer, 2011, v. 4, n. 1, p. 26, doi. 10.1016/j.cloc.2011.04.003
- By:
- Publication type:
- Article